LA JOLLA, Calif., Nov. 27 /PRNewswire-FirstCall/ -- TorreyPines Therapeutics, Inc. today announced that Dr. Michael Murphy, Chief Medical Officer of TorreyPines, will present at the BMO Capital Markets Focus on Healthcare Conference in New York on Tuesday, December 4th at 3:00 p.m., eastern.
A webcast of Dr. Murphy's presentation will be available live. You can access the webcast at: http://www.torreypinestherapeutics.com. An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.
About TorreyPines Therapeutics
TorreyPines Therapeutics, Inc. is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel small molecules to treat diseases and disorders of the central nervous system (CNS). Led by an accomplished management team, TorreyPines is leveraging novel drug targets and technologies to potentially deliver new CNS therapies for chronic pain, including migraine and neuropathic pain; and cognitive disorders, including cognitive impairment associated with schizophrenia and Alzheimer's disease. Further information is available at http://www.torreypinestherapeutics.com.
CONTACT: Craig Johnson of TorreyPines Therapeutics, Inc., +1-858-623-5665,
x158, cjohnson@torreypinestherapeutics.com; or David Schull of Russo
Partners, LLC, +1-212-845-4271, david.schull@russopartnersllc.com; or
investor, Rhonda Chiger of Rx Communications, +1-917-322-2569,
rchiger@rxir.com; or investor, John Baldissera of BPC Financial Marketing,
1-800-368-1217, all for TorreyPines Therapeutics, Inc.
Web site: http://www.torreypinestherapeutics.com/
